Peritoneal and Retroperitoneal Neoplasm

Observed

← altered in cohorts of

AVPR1A

70 / 92 cases (76 %) · ssm · TCGA-ACC

—

Observed

← altered in cohorts of

BAZ2A

70 / 92 cases (76 %) · ssm · TCGA-ACC

—

Observed

← altered in cohorts of

CAND1

70 / 92 cases (76 %) · ssm · TCGA-ACC

—

Observed

← altered in cohorts of

HSD17B6

70 / 92 cases (76 %) · ssm · TCGA-ACC

—

Observed

← altered in cohorts of

NACA

70 / 92 cases (76 %) · ssm · TCGA-ACC

—

Observed

← altered in cohorts of

AGAP2

69 / 92 cases (75 %) · ssm · TCGA-ACC

—

Observed

← altered in cohorts of

ATP23

69 / 92 cases (75 %) · ssm · TCGA-ACC

—

Observed

← altered in cohorts of

ATP5F1B

69 / 92 cases (75 %) · ssm · TCGA-ACC

—

Observed

← altered in cohorts of

AVIL

69 / 92 cases (75 %) · ssm · TCGA-ACC

—

Observed

← altered in cohorts of

BIN2

69 / 92 cases (75 %) · ssm · TCGA-ACC

—

Observed

← altered in cohorts of

CDK4

69 / 92 cases (75 %) · ssm · TCGA-ACC

—

Observed

← altered in cohorts of

CTDSP2

69 / 92 cases (75 %) · ssm · TCGA-ACC

—

Observed

← altered in cohorts of

CYP27B1

69 / 92 cases (75 %) · ssm · TCGA-ACC

—

Observed

← altered in cohorts of

DYRK2

69 / 92 cases (75 %) · ssm · TCGA-ACC

—

Observed

Peritoneal and Retroperitoneal Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived142 of 142show fewer
→ investigated in trials for	Paclitaxelsmall molecule 89 trials (22 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	89	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatinsmall molecule 82 trials (22 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	82	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal antibody 60 trials (23 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	60	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumabmonoclonal antibody 35 trials (17 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	35	Observed	clinicaltrials	graph →
→ investigated in trials for	Doxorubicinsmall molecule 33 trials (8 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	33	Observed	clinicaltrials	graph →
→ investigated in trials for	Cisplatinsmall molecule 32 trials (8 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	32	Observed	clinicaltrials	graph →
→ investigated in trials for	Gemcitabinesmall molecule 27 trials (11 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	27	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyclophosphamidesmall molecule 26 trials (7 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	26	Observed	clinicaltrials	graph →
→ investigated in trials for	Topotecansmall molecule 26 trials (4 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	26	Observed	clinicaltrials	graph →
→ investigated in trials for	Olaparibsmall molecule 24 trials (16 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	24	Observed	clinicaltrials	graph →
→ investigated in trials for	Nivolumabmonoclonal antibody 17 trials (6 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	17	Observed	clinicaltrials	graph →
→ investigated in trials for	Niraparibsmall molecule 13 trials (5 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Docetaxelsmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Pemetrexedsmall molecule 11 trials (3 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Cabozantinibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Atezolizumabmonoclonal antibody 8 trials (5 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Chemotherapy 8 trials (3 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipilimumabmonoclonal antibody 8 trials (3 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Letrozolesmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Mirvetuximab Soravtansineadc 8 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Rucaparibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Veliparibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Cediranibsmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Durvalumabmonoclonal antibody 7 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Filgrastimother 7 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Mitotanesmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Oxaliplatinsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Everolimussmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Nab-paclitaxel 6 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Tremelimumabmonoclonal antibody 6 trials (2 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabinesmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Fluorouracilsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Pazopanibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Adjuvant Chemotherapy 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Aldesleukinother 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Lenvatinibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Pegfilgrastimother 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Talazoparibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Tamoxifensmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Temozolomidesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Adavosertibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Axitinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Capecitabinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Cemiplimabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Cixutumumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Decitabinesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Erlotinib Hydrochloridesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Hyperthermic Intraperitoneal Chemotherapy 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Ifosfamidesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Leucovorinsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Mitomycinsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Selumetinibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Sunitinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Temsirolimussmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Abemaciclibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Avelumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Berzosertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Camrelizumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Carboplatin/Paclitaxel Regimen 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Celecoxibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Cobimetinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Copanlisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Dasatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Dexamethasonesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Dostarlimabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Dovitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Eribulinsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Etoposidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Fulvestrantsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Gefitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Guadecitabinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Ipatasertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Irinotecansmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Lutetium (177lu) Oxodotreotideother 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Melphalansmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Nilotinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Nintedanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Palbociclibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Pertuzumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Sorafenib Tosylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Vatalanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Vorinostatsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Abexinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Abiraterone Acetatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Akt Inhibitor MK2206 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Alemtuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Alisertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Alpelisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Anastrozolesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Anti-VEGF Monoclonal Antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Aspirinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Belinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Belzutifansmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Bendamustinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Binimetinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Bortezomibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Bosutinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Cabazitaxelsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Capivasertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Carfilzomibother 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Cetuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Dordavipronesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Elimusertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Enzalutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Enzastaurinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Erlotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	FOLFOX Regimen 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ganetespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Interferon Alfa-2bother 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Lapatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Lenalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Linsitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Neratinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Onalespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Panitumumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Peginterferon Alfa-2bother 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Pralatrexatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ramucirumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ribociclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Rilotumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Ruxolitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sacituzumab Govitecanadc 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sapanisertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Selinexorsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Seribantumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Sotorasibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Streptozocinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Talimogene Laherparepvecgene therapy 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Taxol 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Therapeutic Tumor Infiltrating Lymphocytes 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Tipifarnibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Tislelizumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Tisotumab Vedotinadc 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Tivozanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Trabectedinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Trametinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Trastuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Vandetanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Vismodegibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Vistusertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Peritoneal and Retroperitoneal Neoplasm	1	Observed	clinicaltrials	graph →

Peritoneal and Retroperitoneal Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived142 of 142show fewer

→ investigated in trials for

Paclitaxelsmall molecule

89 trials (22 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Carboplatinsmall molecule

82 trials (22 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bevacizumabmonoclonal antibody

60 trials (23 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pembrolizumabmonoclonal antibody

35 trials (17 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Doxorubicinsmall molecule

33 trials (8 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cisplatinsmall molecule

32 trials (8 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Gemcitabinesmall molecule

27 trials (11 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cyclophosphamidesmall molecule

26 trials (7 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Topotecansmall molecule

26 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Olaparibsmall molecule

24 trials (16 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nivolumabmonoclonal antibody

17 trials (6 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Niraparibsmall molecule

13 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Docetaxelsmall molecule

11 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pemetrexedsmall molecule

11 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cabozantinibsmall molecule

10 trials (4 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Atezolizumabmonoclonal antibody

8 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Chemotherapy

8 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipilimumabmonoclonal antibody

8 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Letrozolesmall molecule

8 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mirvetuximab Soravtansineadc

8 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Rucaparibsmall molecule

8 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Veliparibsmall molecule

8 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cediranibsmall molecule

7 trials (5 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Durvalumabmonoclonal antibody

7 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Filgrastimother

7 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mitotanesmall molecule

7 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Oxaliplatinsmall molecule

7 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Everolimussmall molecule

6 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nab-paclitaxel

6 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tremelimumabmonoclonal antibody

6 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fludarabinesmall molecule

5 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fluorouracilsmall molecule

5 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pazopanibsmall molecule

5 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Adjuvant Chemotherapy

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aldesleukinother

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lenvatinibsmall molecule

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pegfilgrastimother

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Talazoparibsmall molecule

4 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tamoxifensmall molecule

4 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Temozolomidesmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Adavosertibsmall molecule

3 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Axitinibsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Capecitabinesmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cemiplimabmonoclonal antibody

3 trials (3 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cixutumumabmonoclonal antibody

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Decitabinesmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erlotinib Hydrochloridesmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Hyperthermic Intraperitoneal Chemotherapy

→ investigated in trials for

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ifosfamidesmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Leucovorinsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mitomycinsmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Selumetinibsmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sunitinibsmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Temsirolimussmall molecule

3 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abemaciclibsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Avelumabmonoclonal antibody

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Berzosertibsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Camrelizumabmonoclonal antibody

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

Carboplatin/Paclitaxel Regimen

→ investigated in trials for

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Celecoxibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cobimetinibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Copanlisibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dasatinibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dexamethasonesmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dostarlimabmonoclonal antibody

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dovitinibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Eribulinsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Etoposidesmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fulvestrantsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Gefitinibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Guadecitabinesmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ipatasertibsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Irinotecansmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lutetium (177lu) Oxodotreotideother

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Melphalansmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nilotinibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nintedanibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Palbociclibsmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pertuzumabmonoclonal antibody

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sorafenib Tosylatesmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vatalanibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vorinostatsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abexinostatsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abiraterone Acetatesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Akt Inhibitor MK2206

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alemtuzumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alisertibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Alpelisibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Anastrozolesmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

Anti-VEGF Monoclonal Antibody

→ investigated in trials for

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aspirinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Belinostatsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Belzutifansmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bendamustinesmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Binimetinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bortezomibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bosutinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cabazitaxelsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Capivasertibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Carfilzomibother

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cetuximabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Dordavipronesmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Elimusertibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Enzalutamidesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Enzastaurinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Erlotinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

FOLFOX Regimen

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ganetespibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Interferon Alfa-2bother

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lapatinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lenalidomidesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Linsitinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Neratinibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Onalespibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Panitumumabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Peginterferon Alfa-2bother

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pralatrexatesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ramucirumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ribociclibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Rilotumumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ruxolitinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sacituzumab Govitecanadc

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sapanisertibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Selinexorsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Seribantumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sirolimussmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sorafenibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Sotorasibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Streptozocinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Talimogene Laherparepvecgene therapy

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Taxol

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Therapeutic Tumor Infiltrating Lymphocytes

→ investigated in trials for

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tipifarnibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tislelizumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tisotumab Vedotinadc

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Tivozanibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trabectedinsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trametinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trastuzumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vandetanibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vismodegibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Vistusertibsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

Peritoneal and Retroperitoneal Neoplasm studied in …STUDIED_INderived10 of 887show all (up to 200)
→ studied in	NCT00005927completed Study of Adrenal Gland Tumors · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active)	—	—	Adrenal Gland Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT05564377Phase 2 · recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial · condition mapped CURATED_BROADER · 887 trials mapped (257 active)	—	—	Primary Peritoneal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06487481Phase 1 · recruiting Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma · condition mapped ALIAS · 887 trials mapped (257 active)	—	—	Adrenal Cortical Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07277413Phase 1 · recruiting A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors · condition mapped ALIAS · 887 trials mapped (257 active)	—	—	Peritoneal Mesothelial Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT07504588Phase 2 · recruiting Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy · condition mapped CURATED_BROADER · 887 trials mapped (257 active)	—	—	Platinum-Sensitive Primary Peritoneal Endometrioid Adenocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07715903Phase 1 · not yet recruiting Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy · condition mapped ALIAS · 887 trials mapped (257 active)	—	—	Adrenal Cortical Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05257408Phase 3 · active not recruiting Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active)	—	—	Peritoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT06057935Phase 2 · recruiting A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma · condition mapped ALIAS · 887 trials mapped (257 active)	—	—	Peritoneal Malignant Mesothelioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07776691Phase 3 · recruiting A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04) · condition mapped ALIAS · 887 trials mapped (257 active)	—	—	Malignant Peritoneal Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT07708753Phase 3 · recruiting A Study of SYS6043 in Platinum-Resistant, Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancers · condition mapped ALIAS · 887 trials mapped (257 active)	—	—	Platinum-Resistant Primary Peritoneal Carcinoma	1	Observed	clinicaltrials	graph →

Peritoneal and Retroperitoneal Neoplasm studied in …STUDIED_INderived10 of 887show all (up to 200)

→ studied in

NCT00005927completed

Study of Adrenal Gland Tumors · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active)

—

Adrenal Gland Neoplasm

Observed

Primary Peritoneal Carcinoma

→ studied in

NCT05564377Phase 2 · recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial · condition mapped CURATED_BROADER · 887 trials mapped (257 active)

—

Observed

→ studied in

NCT06487481Phase 1 · recruiting

Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma · condition mapped ALIAS · 887 trials mapped (257 active)

—

Observed

Peritoneal Mesothelial Neoplasm

→ studied in

NCT07277413Phase 1 · recruiting

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors · condition mapped ALIAS · 887 trials mapped (257 active)

—

Observed

Platinum-Sensitive Primary Peritoneal Endometrioid Adenocarcinoma

→ studied in

NCT07504588Phase 2 · recruiting

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy · condition mapped CURATED_BROADER · 887 trials mapped (257 active)

—

Observed

→ studied in

NCT07715903Phase 1 · not yet recruiting

Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy · condition mapped ALIAS · 887 trials mapped (257 active)

—

Observed

→ studied in

NCT05257408Phase 3 · active not recruiting

Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer · condition mapped ONTOLOGY_EXACT · 887 trials mapped (257 active)

—

Peritoneal Neoplasm

Observed

Peritoneal Malignant Mesothelioma

→ studied in

NCT06057935Phase 2 · recruiting

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma · condition mapped ALIAS · 887 trials mapped (257 active)

—

Observed

Malignant Peritoneal Neoplasm

→ studied in

NCT07776691Phase 3 · recruiting

A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04) · condition mapped ALIAS · 887 trials mapped (257 active)

—

Observed

Platinum-Resistant Primary Peritoneal Carcinoma

→ studied in

NCT07708753Phase 3 · recruiting

A Study of SYS6043 in Platinum-Resistant, Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancers · condition mapped ALIAS · 887 trials mapped (257 active)

—

Observed